Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM.

Cell. 1996 Nov 29;87(5):803-9.

PMID:
8945508
[PubMed - indexed for MEDLINE]
Free Article
2.

Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.

Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S.

Cancer Res. 2001 Aug 15;61(16):6131-6.

PMID:
11507063
[PubMed - indexed for MEDLINE]
Free Article
3.

COX-2 and colon cancer.

Taketo MM.

Inflamm Res. 1998 Oct;47 Suppl 2:S112-6.

PMID:
9831333
[PubMed - indexed for MEDLINE]
4.

Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.

Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E, Taketo MM, Evans JF.

Cancer Res. 2001 Feb 15;61(4):1733-40.

PMID:
11245490
[PubMed - indexed for MEDLINE]
Free Article
5.

Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522.

Sasai H, Masaki M, Wakitani K.

Carcinogenesis. 2000 May;21(5):953-8.

PMID:
10783317
[PubMed - indexed for MEDLINE]
Free Article
6.

Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, Bertagnolli MM.

Cancer Res. 1996 Jun 1;56(11):2556-60.

PMID:
8653697
[PubMed - indexed for MEDLINE]
Free Article
7.

COX selectivity and animal models for colon cancer.

Oshima M, Taketo MM.

Curr Pharm Des. 2002;8(12):1021-34. Review.

PMID:
11945149
[PubMed - indexed for MEDLINE]
8.

Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.

Seno H, Oshima M, Ishikawa TO, Oshima H, Takaku K, Chiba T, Narumiya S, Taketo MM.

Cancer Res. 2002 Jan 15;62(2):506-11.

PMID:
11809702
[PubMed - indexed for MEDLINE]
Free Article
9.

[The transgenic mouse model of familial polyposis coli].

Fehmann HC, Eissele R.

Z Gastroenterol. 1997 Nov;35(11):1035-7. German. No abstract available.

PMID:
9490555
[PubMed - indexed for MEDLINE]
10.

Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level.

Hsi LC, Angerman-Stewart J, Eling TE.

Carcinogenesis. 1999 Nov;20(11):2045-9.

PMID:
10545404
[PubMed - indexed for MEDLINE]
Free Article
11.

Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.

Kitamura T, Itoh M, Noda T, Matsuura M, Wakabayashi K.

Int J Cancer. 2004 Apr 20;109(4):576-80.

PMID:
14991580
[PubMed - indexed for MEDLINE]
12.

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.

Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, Oshima M, Taketo MM.

Nat Med. 2001 Sep;7(9):1048-51.

PMID:
11533709
[PubMed - indexed for MEDLINE]
13.

The inducible prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in patients with attenuated adenomatous polyposis coli.

Spirio LN, Dixon DA, Robertson J, Robertson M, Barrows J, Traer E, Burt RW, Leppert MF, White R, Prescott SM.

Cancer Res. 1998 Nov 1;58(21):4909-12.

PMID:
9809998
[PubMed - indexed for MEDLINE]
Free Article
14.

Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice.

Vane J.

Jpn J Cancer Res. 1997 Nov;88(11):inside front cover. No abstract available.

PMID:
9439674
[PubMed - indexed for MEDLINE]
15.

Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.

Jacoby RF, Cole CE, Tutsch K, Newton MA, Kelloff G, Hawk ET, Lubet RA.

Cancer Res. 2000 Apr 1;60(7):1864-70.

PMID:
10766173
[PubMed - indexed for MEDLINE]
Free Article
16.

Piroxicam-induced regression of intestinal adenomatous polyps in APC(delta474) mice.

Qiu ZF, Maruyama K, Sunayama K, Kashiwabara H, Shoji T, Nakamura T, Suzuki S, Konno H, Nakamura S.

J Invest Surg. 2003 Mar-Apr;16(2):71-81.

PMID:
12746190
[PubMed - indexed for MEDLINE]
17.

Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive.

Lew JI, Guo Y, Kim RK, Vargish L, Michelassi F, Arenas RB.

J Gastrointest Surg. 2002 Jul-Aug;6(4):563-8.

PMID:
12127122
[PubMed - indexed for MEDLINE]
18.

Cyclooxygenase-2: a novel target for cancer chemotherapy?

Dempke W, Rie C, Grothey A, Schmoll HJ.

J Cancer Res Clin Oncol. 2001 Jul;127(7):411-7. Review.

PMID:
11469677
[PubMed - indexed for MEDLINE]
19.

Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps.

Sonoshita M, Takaku K, Oshima M, Sugihara K, Taketo MM.

Cancer Res. 2002 Dec 1;62(23):6846-9.

PMID:
12460897
[PubMed - indexed for MEDLINE]
Free Article
20.

[COX-2 associated loss of apoptosis activity in intestinal neoplams in Apc gene knock-out mice].

Schmehl K, Jacobasch G, Buhr HJ.

Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):479-83. German.

PMID:
14518302
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk